CICP, VICP, MDL & Appellate
Case Directory

VICP petition alleging myocarditis following Moderna COVID-19 mRNA vaccination. Special master issued decision on entitlement; parties reached stipulated damages award.

VICP petition for pericarditis following Pfizer-BioNTech BNT162b2 second dose. Causation briefing submitted; special master review pending.

VICP petition alleging SIRVA (shoulder injury related to vaccine administration) following mRNA COVID-19 booster. Medical records review ongoing.

VICP petition for Guillain-Barré syndrome following Moderna mRNA vaccination. Stipulated judgment entered; compensation awarded per VICP Vaccine Injury Table.

VICP petition alleging anaphylaxis within 4 hours of Pfizer BNT162b2 first dose. Entitlement hearing before Special Master Corcoran scheduled.

VICP petition for myocarditis in 17-year-old male following second Pfizer dose. Damages stipulation filed; compensation award entered by special master.

VICP petition alleging vaccine-induced immune thrombocytopenic purpura (ITP) following Moderna booster. Expert report on causation submitted by petitioner.

VICP petition for Bell's palsy following Pfizer BNT162b2 vaccination. Causation disputed; respondent filed expert report challenging Althen prong two.

VICP petition dismissed for failure to establish causation under Althen standard. Petitioner alleged small fiber neuropathy; special master found insufficient medical theory.

VICP petition alleging postural orthostatic tachycardia syndrome (POTS) following Moderna mRNA series. Petitioner filed supplemental expert report on dysautonomia mechanism.

VICP petition for pericarditis and myocarditis (myopericarditis) following Pfizer booster dose. Cardiac MRI records submitted; entitlement briefing underway.

VICP petition for anaphylaxis following Moderna first dose. Stipulated damages agreement reached; compensation award entered covering medical expenses and lost wages.

VICP petition alleging transverse myelitis following Pfizer BNT162b2 vaccination. Neurological expert reports filed by both parties; hearing date set.

VICP petition for chronic inflammatory demyelinating polyneuropathy (CIDP) following Moderna vaccination. Petitioner seeks compensation under off-Table injury theory.

VICP petition alleging myocarditis in 21-year-old male following Pfizer second dose. Cardiac catheterization records and MRI submitted; special master review pending.

VICP petition for SIRVA following Pfizer booster administered in left deltoid. Stipulated damages entered; $95,000 compensation awarded for pain, suffering, and medical costs.

VICP petition alleging Guillain-Barré syndrome following Moderna bivalent booster. Petitioner filed Althen brief; respondent response due.

VICP petition for acute disseminated encephalomyelitis (ADEM) following Pfizer BNT162b2 third dose. Neuroimaging and CSF analysis records submitted.

VICP petition alleging immune thrombocytopenia (ITP) following Moderna mRNA vaccination. Hematology records and bone marrow biopsy submitted to special master.

VICP petition for myocarditis following Pfizer bivalent booster. Petitioner is 24-year-old male; cardiac MRI confirmed myocardial inflammation. Entitlement briefing ordered.

CICP administrative claim for anaphylaxis following Pfizer EUA vaccination. HRSA medical review board found insufficient evidence of causal relationship; claim denied. No appeal mechanism available under CICP.

CICP claim for myocarditis following Moderna EUA vaccination. Medical review determined injury did not meet CICP serious injury threshold. Claimant referred to VICP for potential alternative relief.

CICP claim for thrombosis with thrombocytopenia syndrome (TTS) following Janssen COVID-19 vaccination. Medical records under review by HRSA advisory panel.

CICP claim for post-vaccination encephalitis following Pfizer BNT162b2 booster. Neurological evaluation submitted; HRSA medical review board assessment pending.

CICP claim for vaccine-induced myocarditis denied on causation grounds. HRSA found claimant's cardiac symptoms predated vaccination based on medical record review.

CICP claim for pericarditis following Moderna bivalent booster. Claimant hospitalized for 6 days; cardiac MRI and troponin records submitted. Awaiting HRSA adjudication.

CICP claim for immune thrombocytopenic purpura (ITP) following Pfizer BNT162b2 vaccination. Hematology records and platelet count documentation submitted to HRSA.

CICP claim for Guillain-Barré syndrome following Moderna COVID-19 vaccination. Claimant required hospitalization and physical therapy. Medical review board evaluation ongoing.

Plaintiff alleged fraudulent misrepresentation regarding vaccine efficacy data. Court dismissed on PREP Act immunity grounds; found no willful misconduct exception applied. Affirmed by 4th Circuit.

Challenge to state employee COVID-19 vaccination mandate. Court dismissed; found rational basis for mandate and no cognizable constitutional injury. Cited Jacobson v. Massachusetts.

Challenge to university COVID-19 vaccination requirement. Court dismissed for lack of standing; plaintiff graduated before case was decided. 6th Circuit affirmed dismissal.

Students challenged university COVID-19 vaccination mandate. District court denied preliminary injunction; 7th Circuit (Judge Easterbrook) affirmed, citing Jacobson. Supreme Court denied certiorari.

Challenge to school district student vaccination mandate. 9th Circuit affirmed dismissal; held school district mandate did not violate constitutional rights under existing precedent.

Hospital employees challenged employer COVID-19 vaccination mandate. Court dismissed; found no cognizable legal claim under Texas or federal law for private employer vaccine requirement.

State of Arizona challenged federal contractor COVID-19 vaccination mandate. Case mooted following Supreme Court stay of OSHA ETS; federal contractor mandate subsequently rescinded.

Navy SEALs challenged military COVID-19 vaccination mandate on religious freedom grounds. Preliminary injunction granted by district court; 5th Circuit reversed. Congress subsequently prohibited discharge for refusal.

Student-athletes challenged university COVID-19 vaccination mandate. 6th Circuit affirmed dismissal; found no constitutional violation in university health and safety requirement.

Airline employees challenged COVID-19 vaccination mandate and accommodation process. 5th Circuit affirmed dismissal of preliminary injunction; found plaintiffs failed to show irreparable harm.

Healthcare workers challenged Oregon state COVID-19 vaccination mandate. Court denied preliminary injunction; found state had compelling interest in protecting vulnerable patient populations.

Healthcare workers sought preliminary injunction against hospital COVID-19 vaccination mandate. Court denied injunction; found plaintiffs failed to demonstrate likelihood of success on merits.

JPML consolidated MDL for personal injury claims alleging cardiac, neurological, and autoimmune injuries from Pfizer-BioNTech COVID-19 mRNA vaccine. Over 300 cases transferred. Discovery coordination order entered.

Plaintiff alleges Moderna misappropriated mRNA technology developed at NIH. Separate from injury claims; involves patent and trade secret disputes over mRNA delivery technology. Trial date set.

Plaintiff alleged Pfizer fraudulently misrepresented vaccine trial data to FDA. Court dismissed; found PREP Act immunity barred claims and plaintiff lacked standing to challenge FDA authorization.

Wrongful death action alleging fatal myocarditis following Pfizer BNT162b2 vaccination. Court dismissed on PREP Act grounds; found no willful misconduct exception. 2nd Circuit appeal filed.

Plaintiff alleged cardiac injury from Pfizer mRNA vaccine. Court dismissed on PREP Act immunity; found plaintiff failed to plead facts sufficient to invoke willful misconduct exception.

Plaintiff alleged Pfizer concealed adverse event data during clinical trials. Court dismissed; PREP Act immunity applied and no willful misconduct exception established on pleadings.

Plaintiff alleged neurological injury from Pfizer COVID-19 vaccine. Court dismissed on PREP Act grounds; 4th Circuit affirmed, holding PREP Act provides broad immunity for covered countermeasures.

Plaintiff alleges myocarditis and permanent cardiac damage following Pfizer BNT162b2 vaccination. Argues willful misconduct exception to PREP Act immunity. Motion to dismiss pending.

Plaintiff alleges Pfizer failed to disclose known risks of myocarditis in adolescent males. Complaint invokes willful misconduct and fraud exceptions to PREP Act. Discovery ordered.

Qui tam action alleging Pfizer submitted false data to FDA in violation of False Claims Act. Court dismissed for lack of standing and failure to plead fraud with particularity under Rule 9(b).

Plaintiff, a clinical trial participant, alleges serious adverse events following Pfizer BNT162b2 trial enrollment. Claims Pfizer failed to report adverse events to FDA. Motion to dismiss briefing complete.

Wrongful death action alleging fatal cardiac arrhythmia following Pfizer booster dose. Plaintiff argues PREP Act willful misconduct exception applies based on post-authorization safety signal data.

Plaintiff alleges Moderna failed to adequately warn of myocarditis risk in young adults. Complaint alleges willful misconduct based on internal safety monitoring data. Discovery ongoing.

Plaintiff alleged Moderna mRNA vaccine caused autoimmune hepatitis. Court dismissed on PREP Act grounds; found no plausible willful misconduct allegation in complaint.

Plaintiff alleges Moderna concealed safety data from DSMB during Phase 3 trials. Invokes False Claims Act and PREP Act willful misconduct exception. Government declined to intervene; case proceeds as relator action.

Plaintiff alleges permanent cardiac damage from Moderna mRNA vaccination. Complaint details hospitalization for myocarditis and ongoing cardiac monitoring. Motion to dismiss pending.

Plaintiff alleges Moderna's mRNA vaccine caused POTS and dysautonomia. Complaint cites published peer-reviewed literature on mRNA vaccine-associated autonomic dysfunction. Discovery ordered.

Employee challenged private employer COVID-19 vaccination mandate. Court dismissed; found no federal or state law prohibition on private employer vaccination requirements for at-will employees.

Federal employees challenged executive order requiring COVID-19 vaccination for federal workers. 5th Circuit initially enjoined mandate; Supreme Court allowed mandate to take effect. Case subsequently mooted.

Healthcare workers challenged New York state COVID-19 vaccination mandate without religious exemption. 2nd Circuit affirmed dismissal; found state had compelling interest and mandate was narrowly tailored.

Plaintiff alleges Pfizer BNT162b2 caused myocarditis requiring cardiac ablation. Complaint invokes California consumer protection statutes alongside PREP Act willful misconduct exception.

Plaintiff alleges Pfizer withheld adverse event data from FDA post-authorization safety reporting. Complaint details cardiac injury and invokes PREP Act willful misconduct exception. Scheduling order entered.

Wrongful death action. Plaintiff's decedent died of cardiac arrest 72 hours after Pfizer booster. Complaint alleges Pfizer had knowledge of elevated cardiac risk and failed to update labeling.

Physicians challenged FDA's statements discouraging ivermectin use. 5th Circuit reversed dismissal, finding physicians had standing; remanded. On remand, court dismissed on merits. 5th Circuit affirmed.

FOIA litigation seeking expedited release of Pfizer BNT162b2 clinical trial data. Court ordered accelerated production schedule. FDA produced 450,000+ pages of clinical trial documents under court order.

Challenge to FDA's EUA authorization of Pfizer COVID-19 vaccine for adolescents. Court dismissed for lack of standing; 9th Circuit affirmed. Petitioners lacked direct injury traceable to FDA authorization.

Challenge to federal employee COVID-19 vaccination mandate. District court initially enjoined mandate; 11th Circuit reversed. Case mooted after mandate rescinded; appeal dismissed.

Service members challenged military COVID-19 vaccination mandate on religious freedom grounds. Court dismissed; found military deference doctrine and rational basis review precluded relief.

Plaintiff alleges Pfizer's BNT162b2 caused long-term cardiac arrhythmia and reduced ejection fraction. Complaint details two hospitalizations and ongoing cardiologist monitoring. Motion to dismiss pending.

Plaintiff alleges Pfizer's COVID-19 mRNA vaccine caused new-onset Type 1 diabetes. Complaint cites published literature on mRNA vaccine-associated pancreatic autoimmunity. Discovery ordered.

Plaintiff alleges Moderna mRNA vaccine caused autoimmune encephalitis. Complaint invokes willful misconduct exception and cites Moderna's internal pharmacovigilance reports. Scheduling conference held.

Plaintiff alleges Moderna's mRNA vaccine caused vaccine-induced thrombotic thrombocytopenia (VITT). Complaint details hospitalization, anticoagulation therapy, and ongoing hematological monitoring.

Plaintiff alleges Pfizer BNT162b2 caused pericarditis and constrictive pericarditis requiring pericardiectomy. Complaint details surgical intervention and invokes PREP Act willful misconduct exception.

Plaintiff alleges Pfizer's COVID-19 mRNA vaccine caused new-onset multiple sclerosis. Complaint cites peer-reviewed literature on molecular mimicry and mRNA vaccine-associated demyelination.

Wrongful death action. Plaintiff's decedent, a 28-year-old, died of sudden cardiac death 48 hours after Pfizer booster. Complaint alleges Pfizer had post-authorization safety signal data showing elevated risk in young adults and failed to update labeling.

Case Management Order No. 4 in MDL 3089 established the bellwether selection process. Parties directed to identify pool of 20 plaintiff cases for initial discovery; court to select 6 bellwether cases for early trial scheduling. Myocarditis and pericarditis claims prioritized.

Court ordered consolidated omnibus briefing on PREP Act immunity across all transferred cases. Defendants filed joint motion to dismiss all claims on immunity grounds. Plaintiffs' opposition brief due; ruling expected to set precedent for entire MDL docket.

Case Management Order No. 8 established coordinated discovery protocols for MDL 3089. Pfizer ordered to produce internal pharmacovigilance reports, DSMB communications, and post-authorization safety monitoring data. Plaintiffs' steering committee designated.

First designated bellwether case in MDL 3089. Plaintiff alleges myocarditis requiring hospitalization and cardiac MRI following Pfizer BNT162b2 second dose in 19-year-old male. Expert discovery underway; Daubert motions anticipated.

Fourth Circuit affirmed district court dismissal on PREP Act immunity grounds. Panel held that PREP Act's liability shield applies broadly to covered countermeasures and that plaintiff's negligence claims did not fall within the willful misconduct exception. Established 4th Circuit precedent on PREP Act scope.

Second Circuit appeal of D. Conn. dismissal in wrongful death myocarditis action. Plaintiff-appellant argues district court applied an overly broad reading of PREP Act immunity and that the willful misconduct exception should apply where manufacturer had actual knowledge of cardiac risk. Oral argument held; decision pending.

Fifth Circuit affirmed E.D. La. dismissal. Panel held that to invoke the PREP Act willful misconduct exception, a plaintiff must plead specific facts showing the manufacturer acted with conscious disregard of a known, serious risk — general allegations of inadequate warning are insufficient. Deepens circuit consensus on pleading standard.

Ninth Circuit affirmed dismissal of challenge to FDA's EUA authorization of Pfizer COVID-19 vaccine for adolescents. Panel held petitioners lacked Article III standing; no direct, traceable injury from FDA's authorization decision. Certiorari petition filed with Supreme Court; denied.

Fifth Circuit affirmed N.D. Tex. dismissal. Court reiterated that PREP Act immunity is jurisdictional — federal courts lack subject matter jurisdiction over covered countermeasure claims absent a viable willful misconduct allegation. Plaintiff's concealment theory found insufficient at pleading stage.

Fourth Circuit affirmed E.D. Va. dismissal of fraudulent misrepresentation claims. Panel held PREP Act immunity extends to claims framed as fraud where the underlying conduct involves the manufacture or administration of a covered countermeasure. Willful misconduct exception requires intentional tortious conduct, not mere negligence or recklessness.

Proposed nationwide class action on behalf of individuals who suffered myocarditis or pericarditis following Pfizer BNT162b2 vaccination. Complaint alleges Pfizer knew of elevated cardiac risk in males under 30 and failed to update labeling. Class certification motion filed; Pfizer opposes on predominance and superiority grounds.

Multi-state class action alleging Moderna's mRNA-1273 vaccine caused cardiac injury in young adult males. Plaintiffs seek class certification for a damages class and an injunctive relief class requiring updated labeling. Moderna moved to dismiss on PREP Act grounds; motion pending.